ArticleReviews in cardiovascular medicine2025
Artificial Intelligence in Cardiac Treatment Decision-Making: An Evaluation of the Performance of ChatGPT Versus the Heart Team in Coronary Revascularization.
Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the performance of two versions of ChatGPT (o1 and 4o) in making decisions about coronary revascularization and to compare the recommendations of these versions with those of a multidisciplinary Heart Team. Moreover, the study aimed to assess whether the decisions generated by ChatGPT, based on the internal knowledge base of the system and clinical guidelines, align with expert recommendations in real-world coronary artery disease management. Given the increasing prevalence and processing capabilities of large language models, such as ChatGPT, this comparison offers insights into the potential applicability of these systems in complex clinical decision-making. Methods: We conducted a retrospective study at a single center, which included 128 patients who underwent coronary angiography between August and September 2024. The demographics, medical history, current medications, echocardiographic findings, and angiographic findings for each patient were provided to the two ChatGPT versions. The two models were then asked to choose one of three treatment options: coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or medical therapy, and to justify their choice. Performance was assessed using metrics such as accuracy, sensitivity, specificity, precision, F1 score, Cohen's kappa, and Shannon's entropy. Results: The Heart Team recommended CABG for 78.1% of the patients, PCI for 12.5%, and medical therapy for 9.4%. ChatGPT o1 demonstrated higher sensitivity in identifying patients who needed CABG (82%) but lower sensitivity for PCI (43.7%), whereas ChatGPT 4o performed better in recognizing PCI candidates (68.7%) but was less accurate for CABG cases (43%). Both models struggled to identify patients suitable for medical therapy, with no correct predictions in this category. Agreement with the Heart Team was low (Cohen's kappa: 0.17 for o1 and 0.03 for 4o). Notably, these errors were often attributed to the limited understanding of the model in a clinical context and the inability to analyze angiographic images directly. Conclusion: While ChatGPT-based artificial intelligence (AI) models show promise in assisting with cardiac care decisions, the current limitations of these models emphasize the need for further development. Incorporating imaging data and enhancing comprehension of clinical context is essential to improve the reliability of these AI models in real-world medical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.